,,owww,,,,,,,,we all no doubt agree with you about share price.....its my position that with approx. 200 CNS drugs out there that need to be tested in the brain that a few more brave souls in BP will want our technology,,,,,,,,,,and the sooner the better!,,,,,what happens if we do show excellent BBB penetration in our clinical trial??....what then??,,,,What will the sideliners do with the other 199 drugs sitting in limbo!!!,,,good grief Charlie Brown!!,,,,it is sort of depressing that BP or medium sized pharma is not jumping at the chance to research their possibilities around xB3,,,,jmo

*** I had thought that the BUZZ of Bio would ahve drawn in some deep pockets before the end of Feb,,but it seems the opposite,,,but as an optimist maybe its the March target ,,end of quarter !!